128 related articles for article (PubMed ID: 21170085)
1. Cyclin-dependent kinase 1 expression is inhibited by p16(INK4a) at the post-transcriptional level through the microRNA pathway.
Chien WW; Domenech C; Catallo R; Kaddar T; Magaud JP; Salles G; Ffrench M
Oncogene; 2011 Apr; 30(16):1880-91. PubMed ID: 21170085
[TBL] [Abstract][Full Text] [Related]
2. Cyclin E and c-Myc promote cell proliferation in the presence of p16INK4a and of hypophosphorylated retinoblastoma family proteins.
Alevizopoulos K; Vlach J; Hennecke S; Amati B
EMBO J; 1997 Sep; 16(17):5322-33. PubMed ID: 9311992
[TBL] [Abstract][Full Text] [Related]
3. The inhibitor of cyclin-dependent kinase 4a/alternative reading frame (INK4a/ARF) locus encoded proteins p16INK4a and p19ARF repress cyclin D1 transcription through distinct cis elements.
D'Amico M; Wu K; Fu M; Rao M; Albanese C; Russell RG; Lian H; Bregman D; White MA; Pestell RG
Cancer Res; 2004 Jun; 64(12):4122-30. PubMed ID: 15205322
[TBL] [Abstract][Full Text] [Related]
4. Expression of p16 induces transcriptional downregulation of the RB gene.
Fang X; Jin X; Xu HJ; Liu L; Peng HQ; Hogg D; Roth JA; Yu Y; Xu F; Bast RC; Mills GB
Oncogene; 1998 Jan; 16(1):1-8. PubMed ID: 9467937
[TBL] [Abstract][Full Text] [Related]
5. S-phase lengthening induced by p16(INK4a) overexpression in malignant cells with wild-type pRb and p53.
Chien WW; Domenech C; Catallo R; Salles G; Ffrench M
Cell Cycle; 2010 Aug; 9(16):3286-96. PubMed ID: 20703084
[TBL] [Abstract][Full Text] [Related]
6. JunB suppresses cell proliferation by transcriptional activation of p16(INK4a) expression.
Passegué E; Wagner EF
EMBO J; 2000 Jun; 19(12):2969-79. PubMed ID: 10856241
[TBL] [Abstract][Full Text] [Related]
7. The role of p16 in the E2F-dependent thymidine kinase regulation.
Hengstschläger M; Hengstschläger-Ottnad E; Pusch O; Wawra E
Oncogene; 1996 Apr; 12(8):1635-43. PubMed ID: 8622883
[TBL] [Abstract][Full Text] [Related]
8. Disruption of the pRb/E2F pathway and inhibition of apoptosis are major oncogenic events in liver constitutively expressing c-myc and transforming growth factor alpha.
Santoni-Rugiu E; Jensen MR; Thorgeirsson SS
Cancer Res; 1998 Jan; 58(1):123-34. PubMed ID: 9426068
[TBL] [Abstract][Full Text] [Related]
9. Recovery of function in osteoarthritic chondrocytes induced by p16INK4a-specific siRNA in vitro.
Zhou HW; Lou SQ; Zhang K
Rheumatology (Oxford); 2004 May; 43(5):555-68. PubMed ID: 15026580
[TBL] [Abstract][Full Text] [Related]
10. Cell cycle arrest and cytochrome c-mediated apoptotic induction by MCS-5A is associated with up-regulation of p16(INK4a) in HL-60 cells.
Choi BY; Lee CH
Bioorg Med Chem Lett; 2010 Jul; 20(13):3880-4. PubMed ID: 20627562
[TBL] [Abstract][Full Text] [Related]
11. P300 plays a role in p16(INK4a) expression and cell cycle arrest.
Wang X; Pan L; Feng Y; Wang Y; Han Q; Han L; Han S; Guo J; Huang B; Lu J
Oncogene; 2008 Mar; 27(13):1894-904. PubMed ID: 17906698
[TBL] [Abstract][Full Text] [Related]
12. Cell cycle deregulation in liver lesions of rats with and without genetic predisposition to hepatocarcinogenesis.
Pascale RM; Simile MM; De Miglio MR; Muroni MR; Calvisi DF; Asara G; Casabona D; Frau M; Seddaiu MA; Feo F
Hepatology; 2002 Jun; 35(6):1341-50. PubMed ID: 12029619
[TBL] [Abstract][Full Text] [Related]
13. Expression of cell-cycle mediators in ovarian cancer cells after transfection with p16(INK4a), p21(WAF1/Cip-1), and p53.
Ramirez PT; Gershenson DM; Tortolero-Luna G; Ramondetta LM; Fightmaster D; Wharton JT; Wolf JK
Gynecol Oncol; 2001 Dec; 83(3):543-8. PubMed ID: 11733969
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of E2F-1 is associated with increased disease-free survival in squamous cell carcinoma of the anterior tongue.
Kwong RA; Nguyen TV; Bova RJ; Kench JG; Cole IE; Musgrove EA; Henshall SM; Sutherland RL
Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3705-11. PubMed ID: 14506162
[TBL] [Abstract][Full Text] [Related]
15. G1 arrest by p16INK4A uncouples growth from cell cycle progression in leukemia cells with deregulated cyclin E and c-Myc expression.
Ausserlechner MJ; Obexer P; Geley S; Kofler R
Leukemia; 2005 Jun; 19(6):1051-7. PubMed ID: 15800668
[TBL] [Abstract][Full Text] [Related]
16. The physiology of p16(INK4A)-mediated G1 proliferative arrest.
Shapiro GI; Edwards CD; Rollins BJ
Cell Biochem Biophys; 2000; 33(2):189-97. PubMed ID: 11325039
[TBL] [Abstract][Full Text] [Related]
17. Consistent inactivation of p19(Arf) but not p15(Ink4b) in murine myeloid cells transformed in vivo by deregulated c-Myc.
Haviernik P; Schmidt M; Hu X; Wolff L
Oncogene; 2003 Mar; 22(11):1600-10. PubMed ID: 12642863
[TBL] [Abstract][Full Text] [Related]
18. The role of Ink4a/Arf in ErbB2 mammary gland tumorigenesis.
D'Amico M; Wu K; Di Vizio D; Reutens AT; Stahl M; Fu M; Albanese C; Russell RG; Muller WJ; White M; Negassa A; Lee HW; DePinho RA; Pestell RG
Cancer Res; 2003 Jun; 63(12):3395-402. PubMed ID: 12810676
[TBL] [Abstract][Full Text] [Related]
19. Alterations of cell cycle regulators affecting the RB pathway in nonfamilial retinoblastoma.
Orjuela M; Orlow I; Dudas M; Ponce-Castañeda MV; Ridaura C; Leal C; Salazar A; Abramson D; Gerald W; Cordon-Cardo C
Hum Pathol; 2001 May; 32(5):537-44. PubMed ID: 11381373
[TBL] [Abstract][Full Text] [Related]
20. PTHrP signaling targets cyclin D1 and induces osteoblastic cell growth arrest.
Datta NS; Chen C; Berry JE; McCauley LK
J Bone Miner Res; 2005 Jun; 20(6):1051-64. PubMed ID: 15883646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
